Global Regenerative Medicine Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Page: 155

Published Date: 13 Jan 2025

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Regenerative Medicine market size was valued at US$ 48660 million in 2024 and is forecast to a readjusted size of USD 160020 million by 2031 with a CAGR of 18.7% during review period.

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function". It is through the use of innovative medical means rebuilding diseased or damaged tissue or to support diseased or damaged tissue regeneration. The methods used include cell therapy, tissue engineering, chemically induced and therapeutic cloning, etc. Any combination of these technologies may be used to harness or stimulate the body’s innate healing ability in order to treat a wide range of ailments, including musculoskeletal-related conditions, cardio- and peripheral vascular diseases, neurological disorders, stroke, non-healing wounds and ocular diseases.

Regenerative medicine is defined as the process of replacing or "regenerating" human cells, tissues or organs to restore or establish normal function and has been called the "next evolution of medical treatments" and “the vanguard of 21st century healthcare” by the U.S. Department of Health and Human Services.

Global Regenerative Medicine key players include J & J (DePuy Synthes), Medtronic, Allergan(Acelity), Zimmer Biomet, etc. Global top four manufacturers hold a share about 10%.

North America is the largest market, with a share about 25%, followed by Europe, and Asia Pacific, both have a share over 40 percent.

In terms of product, Tissue Engineering is the largest segment, with a share over 40%. And in terms of application, the largest application is Dermatology, followed by Cardiovascular, CNS, Orthopedic, etc.

This report is a detailed and comprehensive analysis for global Regenerative Medicine market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:
Global Regenerative Medicine market size and forecasts, in consumption value ($ Million), 2020-2031
Global Regenerative Medicine market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Regenerative Medicine market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Regenerative Medicine market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Regenerative Medicine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Regenerative Medicine market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include J & J (DePuy Synthes), Medtronic, Zimmer Biomet, Stryker, Allergan(Acelity), MiMedx Group, Organogenesis, Fujifilm Cellular Dynamics, Osiris Therapeutics, Vcanbio, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation
Regenerative Medicine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Cell Therapy
    Tissue Engineering
    Biomaterial
    Other

Market segment by Application
    Dermatology
    Cardiovascular
    CNS
    Orthopedic
    Others

Market segment by players, this report covers
    J & J (DePuy Synthes)
    Medtronic
    Zimmer Biomet
    Stryker
    Allergan(Acelity)
    MiMedx Group
    Organogenesis
    Fujifilm Cellular Dynamics
    Osiris Therapeutics
    Vcanbio
    CCBC
    Cytori
    Celgene
    Vericel Corporation
    Guanhao Biotech
    Mesoblast
    AMAG Pharmaceuticals (CBR)
    ViaCord
    CordLife
    Integra LifeSciences
    Nuvasive
    Cook Biotech
    Japan Tissue Engineering

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Regenerative Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Regenerative Medicine, with revenue, gross margin, and global market share of Regenerative Medicine from 2020 to 2025.
Chapter 3, the Regenerative Medicine competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Regenerative Medicine market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Regenerative Medicine.
Chapter 13, to describe Regenerative Medicine research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Regenerative Medicine by Type
        1.3.1 Overview: Global Regenerative Medicine Market Size by Type: 2020 Versus 2024 Versus 2031
        1.3.2 Global Regenerative Medicine Consumption Value Market Share by Type in 2024
        1.3.3 Cell Therapy
        1.3.4 Tissue Engineering
        1.3.5 Biomaterial
        1.3.6 Other
    1.4 Global Regenerative Medicine Market by Application
        1.4.1 Overview: Global Regenerative Medicine Market Size by Application: 2020 Versus 2024 Versus 2031
        1.4.2 Dermatology
        1.4.3 Cardiovascular
        1.4.4 CNS
        1.4.5 Orthopedic
        1.4.6 Others
    1.5 Global Regenerative Medicine Market Size & Forecast
    1.6 Global Regenerative Medicine Market Size and Forecast by Region
        1.6.1 Global Regenerative Medicine Market Size by Region: 2020 VS 2024 VS 2031
        1.6.2 Global Regenerative Medicine Market Size by Region, (2020-2031)
        1.6.3 North America Regenerative Medicine Market Size and Prospect (2020-2031)
        1.6.4 Europe Regenerative Medicine Market Size and Prospect (2020-2031)
        1.6.5 Asia-Pacific Regenerative Medicine Market Size and Prospect (2020-2031)
        1.6.6 South America Regenerative Medicine Market Size and Prospect (2020-2031)
        1.6.7 Middle East & Africa Regenerative Medicine Market Size and Prospect (2020-2031)

2 Company Profiles
    2.1 J & J (DePuy Synthes)
        2.1.1 J & J (DePuy Synthes) Details
        2.1.2 J & J (DePuy Synthes) Major Business
        2.1.3 J & J (DePuy Synthes) Regenerative Medicine Product and Solutions
        2.1.4 J & J (DePuy Synthes) Regenerative Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.1.5 J & J (DePuy Synthes) Recent Developments and Future Plans
    2.2 Medtronic
        2.2.1 Medtronic Details
        2.2.2 Medtronic Major Business
        2.2.3 Medtronic Regenerative Medicine Product and Solutions
        2.2.4 Medtronic Regenerative Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.2.5 Medtronic Recent Developments and Future Plans
    2.3 Zimmer Biomet
        2.3.1 Zimmer Biomet Details
        2.3.2 Zimmer Biomet Major Business
        2.3.3 Zimmer Biomet Regenerative Medicine Product and Solutions
        2.3.4 Zimmer Biomet Regenerative Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.3.5 Zimmer Biomet Recent Developments and Future Plans
    2.4 Stryker
        2.4.1 Stryker Details
        2.4.2 Stryker Major Business
        2.4.3 Stryker Regenerative Medicine Product and Solutions
        2.4.4 Stryker Regenerative Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.4.5 Stryker Recent Developments and Future Plans
    2.5 Allergan(Acelity)
        2.5.1 Allergan(Acelity) Details
        2.5.2 Allergan(Acelity) Major Business
        2.5.3 Allergan(Acelity) Regenerative Medicine Product and Solutions
        2.5.4 Allergan(Acelity) Regenerative Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.5.5 Allergan(Acelity) Recent Developments and Future Plans
    2.6 MiMedx Group
        2.6.1 MiMedx Group Details
        2.6.2 MiMedx Group Major Business
        2.6.3 MiMedx Group Regenerative Medicine Product and Solutions
        2.6.4 MiMedx Group Regenerative Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.6.5 MiMedx Group Recent Developments and Future Plans
    2.7 Organogenesis
        2.7.1 Organogenesis Details
        2.7.2 Organogenesis Major Business
        2.7.3 Organogenesis Regenerative Medicine Product and Solutions
        2.7.4 Organogenesis Regenerative Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.7.5 Organogenesis Recent Developments and Future Plans
    2.8 Fujifilm Cellular Dynamics
        2.8.1 Fujifilm Cellular Dynamics Details
        2.8.2 Fujifilm Cellular Dynamics Major Business
        2.8.3 Fujifilm Cellular Dynamics Regenerative Medicine Product and Solutions
        2.8.4 Fujifilm Cellular Dynamics Regenerative Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.8.5 Fujifilm Cellular Dynamics Recent Developments and Future Plans
    2.9 Osiris Therapeutics
        2.9.1 Osiris Therapeutics Details
        2.9.2 Osiris Therapeutics Major Business
        2.9.3 Osiris Therapeutics Regenerative Medicine Product and Solutions
        2.9.4 Osiris Therapeutics Regenerative Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.9.5 Osiris Therapeutics Recent Developments and Future Plans
    2.10 Vcanbio
        2.10.1 Vcanbio Details
        2.10.2 Vcanbio Major Business
        2.10.3 Vcanbio Regenerative Medicine Product and Solutions
        2.10.4 Vcanbio Regenerative Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.10.5 Vcanbio Recent Developments and Future Plans
    2.11 CCBC
        2.11.1 CCBC Details
        2.11.2 CCBC Major Business
        2.11.3 CCBC Regenerative Medicine Product and Solutions
        2.11.4 CCBC Regenerative Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.11.5 CCBC Recent Developments and Future Plans
    2.12 Cytori
        2.12.1 Cytori Details
        2.12.2 Cytori Major Business
        2.12.3 Cytori Regenerative Medicine Product and Solutions
        2.12.4 Cytori Regenerative Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.12.5 Cytori Recent Developments and Future Plans
    2.13 Celgene
        2.13.1 Celgene Details
        2.13.2 Celgene Major Business
        2.13.3 Celgene Regenerative Medicine Product and Solutions
        2.13.4 Celgene Regenerative Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.13.5 Celgene Recent Developments and Future Plans
    2.14 Vericel Corporation
        2.14.1 Vericel Corporation Details
        2.14.2 Vericel Corporation Major Business
        2.14.3 Vericel Corporation Regenerative Medicine Product and Solutions
        2.14.4 Vericel Corporation Regenerative Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.14.5 Vericel Corporation Recent Developments and Future Plans
    2.15 Guanhao Biotech
        2.15.1 Guanhao Biotech Details
        2.15.2 Guanhao Biotech Major Business
        2.15.3 Guanhao Biotech Regenerative Medicine Product and Solutions
        2.15.4 Guanhao Biotech Regenerative Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.15.5 Guanhao Biotech Recent Developments and Future Plans
    2.16 Mesoblast
        2.16.1 Mesoblast Details
        2.16.2 Mesoblast Major Business
        2.16.3 Mesoblast Regenerative Medicine Product and Solutions
        2.16.4 Mesoblast Regenerative Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.16.5 Mesoblast Recent Developments and Future Plans
    2.17 AMAG Pharmaceuticals (CBR)
        2.17.1 AMAG Pharmaceuticals (CBR) Details
        2.17.2 AMAG Pharmaceuticals (CBR) Major Business
        2.17.3 AMAG Pharmaceuticals (CBR) Regenerative Medicine Product and Solutions
        2.17.4 AMAG Pharmaceuticals (CBR) Regenerative Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.17.5 AMAG Pharmaceuticals (CBR) Recent Developments and Future Plans
    2.18 ViaCord
        2.18.1 ViaCord Details
        2.18.2 ViaCord Major Business
        2.18.3 ViaCord Regenerative Medicine Product and Solutions
        2.18.4 ViaCord Regenerative Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.18.5 ViaCord Recent Developments and Future Plans
    2.19 CordLife
        2.19.1 CordLife Details
        2.19.2 CordLife Major Business
        2.19.3 CordLife Regenerative Medicine Product and Solutions
        2.19.4 CordLife Regenerative Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.19.5 CordLife Recent Developments and Future Plans
    2.20 Integra LifeSciences
        2.20.1 Integra LifeSciences Details
        2.20.2 Integra LifeSciences Major Business
        2.20.3 Integra LifeSciences Regenerative Medicine Product and Solutions
        2.20.4 Integra LifeSciences Regenerative Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.20.5 Integra LifeSciences Recent Developments and Future Plans
    2.21 Nuvasive
        2.21.1 Nuvasive Details
        2.21.2 Nuvasive Major Business
        2.21.3 Nuvasive Regenerative Medicine Product and Solutions
        2.21.4 Nuvasive Regenerative Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.21.5 Nuvasive Recent Developments and Future Plans
    2.22 Cook Biotech
        2.22.1 Cook Biotech Details
        2.22.2 Cook Biotech Major Business
        2.22.3 Cook Biotech Regenerative Medicine Product and Solutions
        2.22.4 Cook Biotech Regenerative Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.22.5 Cook Biotech Recent Developments and Future Plans
    2.23 Japan Tissue Engineering
        2.23.1 Japan Tissue Engineering Details
        2.23.2 Japan Tissue Engineering Major Business
        2.23.3 Japan Tissue Engineering Regenerative Medicine Product and Solutions
        2.23.4 Japan Tissue Engineering Regenerative Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.23.5 Japan Tissue Engineering Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Regenerative Medicine Revenue and Share by Players (2020-2025)
    3.2 Market Share Analysis (2024)
        3.2.1 Market Share of Regenerative Medicine by Company Revenue
        3.2.2 Top 3 Regenerative Medicine Players Market Share in 2024
        3.2.3 Top 6 Regenerative Medicine Players Market Share in 2024
    3.3 Regenerative Medicine Market: Overall Company Footprint Analysis
        3.3.1 Regenerative Medicine Market: Region Footprint
        3.3.2 Regenerative Medicine Market: Company Product Type Footprint
        3.3.3 Regenerative Medicine Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Regenerative Medicine Consumption Value and Market Share by Type (2020-2025)
    4.2 Global Regenerative Medicine Market Forecast by Type (2026-2031)

5 Market Size Segment by Application
    5.1 Global Regenerative Medicine Consumption Value Market Share by Application (2020-2025)
    5.2 Global Regenerative Medicine Market Forecast by Application (2026-2031)

6 North America
    6.1 North America Regenerative Medicine Consumption Value by Type (2020-2031)
    6.2 North America Regenerative Medicine Market Size by Application (2020-2031)
    6.3 North America Regenerative Medicine Market Size by Country
        6.3.1 North America Regenerative Medicine Consumption Value by Country (2020-2031)
        6.3.2 United States Regenerative Medicine Market Size and Forecast (2020-2031)
        6.3.3 Canada Regenerative Medicine Market Size and Forecast (2020-2031)
        6.3.4 Mexico Regenerative Medicine Market Size and Forecast (2020-2031)

7 Europe
    7.1 Europe Regenerative Medicine Consumption Value by Type (2020-2031)
    7.2 Europe Regenerative Medicine Consumption Value by Application (2020-2031)
    7.3 Europe Regenerative Medicine Market Size by Country
        7.3.1 Europe Regenerative Medicine Consumption Value by Country (2020-2031)
        7.3.2 Germany Regenerative Medicine Market Size and Forecast (2020-2031)
        7.3.3 France Regenerative Medicine Market Size and Forecast (2020-2031)
        7.3.4 United Kingdom Regenerative Medicine Market Size and Forecast (2020-2031)
        7.3.5 Russia Regenerative Medicine Market Size and Forecast (2020-2031)
        7.3.6 Italy Regenerative Medicine Market Size and Forecast (2020-2031)

8 Asia-Pacific
    8.1 Asia-Pacific Regenerative Medicine Consumption Value by Type (2020-2031)
    8.2 Asia-Pacific Regenerative Medicine Consumption Value by Application (2020-2031)
    8.3 Asia-Pacific Regenerative Medicine Market Size by Region
        8.3.1 Asia-Pacific Regenerative Medicine Consumption Value by Region (2020-2031)
        8.3.2 China Regenerative Medicine Market Size and Forecast (2020-2031)
        8.3.3 Japan Regenerative Medicine Market Size and Forecast (2020-2031)
        8.3.4 South Korea Regenerative Medicine Market Size and Forecast (2020-2031)
        8.3.5 India Regenerative Medicine Market Size and Forecast (2020-2031)
        8.3.6 Southeast Asia Regenerative Medicine Market Size and Forecast (2020-2031)
        8.3.7 Australia Regenerative Medicine Market Size and Forecast (2020-2031)

9 South America
    9.1 South America Regenerative Medicine Consumption Value by Type (2020-2031)
    9.2 South America Regenerative Medicine Consumption Value by Application (2020-2031)
    9.3 South America Regenerative Medicine Market Size by Country
        9.3.1 South America Regenerative Medicine Consumption Value by Country (2020-2031)
        9.3.2 Brazil Regenerative Medicine Market Size and Forecast (2020-2031)
        9.3.3 Argentina Regenerative Medicine Market Size and Forecast (2020-2031)

10 Middle East & Africa
    10.1 Middle East & Africa Regenerative Medicine Consumption Value by Type (2020-2031)
    10.2 Middle East & Africa Regenerative Medicine Consumption Value by Application (2020-2031)
    10.3 Middle East & Africa Regenerative Medicine Market Size by Country
        10.3.1 Middle East & Africa Regenerative Medicine Consumption Value by Country (2020-2031)
        10.3.2 Turkey Regenerative Medicine Market Size and Forecast (2020-2031)
        10.3.3 Saudi Arabia Regenerative Medicine Market Size and Forecast (2020-2031)
        10.3.4 UAE Regenerative Medicine Market Size and Forecast (2020-2031)

11 Market Dynamics
    11.1 Regenerative Medicine Market Drivers
    11.2 Regenerative Medicine Market Restraints
    11.3 Regenerative Medicine Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Regenerative Medicine Industry Chain
    12.2 Regenerative Medicine Upstream Analysis
    12.3 Regenerative Medicine Midstream Analysis
    12.4 Regenerative Medicine Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Regenerative Medicine Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
 Table 2. Global Regenerative Medicine Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Table 3. Global Regenerative Medicine Consumption Value by Region (2020-2025) & (USD Million)
 Table 4. Global Regenerative Medicine Consumption Value by Region (2026-2031) & (USD Million)
 Table 5. J & J (DePuy Synthes) Company Information, Head Office, and Major Competitors
 Table 6. J & J (DePuy Synthes) Major Business
 Table 7. J & J (DePuy Synthes) Regenerative Medicine Product and Solutions
 Table 8. J & J (DePuy Synthes) Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 9. J & J (DePuy Synthes) Recent Developments and Future Plans
 Table 10. Medtronic Company Information, Head Office, and Major Competitors
 Table 11. Medtronic Major Business
 Table 12. Medtronic Regenerative Medicine Product and Solutions
 Table 13. Medtronic Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 14. Medtronic Recent Developments and Future Plans
 Table 15. Zimmer Biomet Company Information, Head Office, and Major Competitors
 Table 16. Zimmer Biomet Major Business
 Table 17. Zimmer Biomet Regenerative Medicine Product and Solutions
 Table 18. Zimmer Biomet Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 19. Stryker Company Information, Head Office, and Major Competitors
 Table 20. Stryker Major Business
 Table 21. Stryker Regenerative Medicine Product and Solutions
 Table 22. Stryker Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 23. Stryker Recent Developments and Future Plans
 Table 24. Allergan(Acelity) Company Information, Head Office, and Major Competitors
 Table 25. Allergan(Acelity) Major Business
 Table 26. Allergan(Acelity) Regenerative Medicine Product and Solutions
 Table 27. Allergan(Acelity) Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 28. Allergan(Acelity) Recent Developments and Future Plans
 Table 29. MiMedx Group Company Information, Head Office, and Major Competitors
 Table 30. MiMedx Group Major Business
 Table 31. MiMedx Group Regenerative Medicine Product and Solutions
 Table 32. MiMedx Group Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 33. MiMedx Group Recent Developments and Future Plans
 Table 34. Organogenesis Company Information, Head Office, and Major Competitors
 Table 35. Organogenesis Major Business
 Table 36. Organogenesis Regenerative Medicine Product and Solutions
 Table 37. Organogenesis Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 38. Organogenesis Recent Developments and Future Plans
 Table 39. Fujifilm Cellular Dynamics Company Information, Head Office, and Major Competitors
 Table 40. Fujifilm Cellular Dynamics Major Business
 Table 41. Fujifilm Cellular Dynamics Regenerative Medicine Product and Solutions
 Table 42. Fujifilm Cellular Dynamics Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 43. Fujifilm Cellular Dynamics Recent Developments and Future Plans
 Table 44. Osiris Therapeutics Company Information, Head Office, and Major Competitors
 Table 45. Osiris Therapeutics Major Business
 Table 46. Osiris Therapeutics Regenerative Medicine Product and Solutions
 Table 47. Osiris Therapeutics Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 48. Osiris Therapeutics Recent Developments and Future Plans
 Table 49. Vcanbio Company Information, Head Office, and Major Competitors
 Table 50. Vcanbio Major Business
 Table 51. Vcanbio Regenerative Medicine Product and Solutions
 Table 52. Vcanbio Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 53. Vcanbio Recent Developments and Future Plans
 Table 54. CCBC Company Information, Head Office, and Major Competitors
 Table 55. CCBC Major Business
 Table 56. CCBC Regenerative Medicine Product and Solutions
 Table 57. CCBC Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 58. CCBC Recent Developments and Future Plans
 Table 59. Cytori Company Information, Head Office, and Major Competitors
 Table 60. Cytori Major Business
 Table 61. Cytori Regenerative Medicine Product and Solutions
 Table 62. Cytori Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 63. Cytori Recent Developments and Future Plans
 Table 64. Celgene Company Information, Head Office, and Major Competitors
 Table 65. Celgene Major Business
 Table 66. Celgene Regenerative Medicine Product and Solutions
 Table 67. Celgene Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 68. Celgene Recent Developments and Future Plans
 Table 69. Vericel Corporation Company Information, Head Office, and Major Competitors
 Table 70. Vericel Corporation Major Business
 Table 71. Vericel Corporation Regenerative Medicine Product and Solutions
 Table 72. Vericel Corporation Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 73. Vericel Corporation Recent Developments and Future Plans
 Table 74. Guanhao Biotech Company Information, Head Office, and Major Competitors
 Table 75. Guanhao Biotech Major Business
 Table 76. Guanhao Biotech Regenerative Medicine Product and Solutions
 Table 77. Guanhao Biotech Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 78. Guanhao Biotech Recent Developments and Future Plans
 Table 79. Mesoblast Company Information, Head Office, and Major Competitors
 Table 80. Mesoblast Major Business
 Table 81. Mesoblast Regenerative Medicine Product and Solutions
 Table 82. Mesoblast Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 83. Mesoblast Recent Developments and Future Plans
 Table 84. AMAG Pharmaceuticals (CBR) Company Information, Head Office, and Major Competitors
 Table 85. AMAG Pharmaceuticals (CBR) Major Business
 Table 86. AMAG Pharmaceuticals (CBR) Regenerative Medicine Product and Solutions
 Table 87. AMAG Pharmaceuticals (CBR) Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 88. AMAG Pharmaceuticals (CBR) Recent Developments and Future Plans
 Table 89. ViaCord Company Information, Head Office, and Major Competitors
 Table 90. ViaCord Major Business
 Table 91. ViaCord Regenerative Medicine Product and Solutions
 Table 92. ViaCord Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 93. ViaCord Recent Developments and Future Plans
 Table 94. CordLife Company Information, Head Office, and Major Competitors
 Table 95. CordLife Major Business
 Table 96. CordLife Regenerative Medicine Product and Solutions
 Table 97. CordLife Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 98. CordLife Recent Developments and Future Plans
 Table 99. Integra LifeSciences Company Information, Head Office, and Major Competitors
 Table 100. Integra LifeSciences Major Business
 Table 101. Integra LifeSciences Regenerative Medicine Product and Solutions
 Table 102. Integra LifeSciences Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 103. Integra LifeSciences Recent Developments and Future Plans
 Table 104. Nuvasive Company Information, Head Office, and Major Competitors
 Table 105. Nuvasive Major Business
 Table 106. Nuvasive Regenerative Medicine Product and Solutions
 Table 107. Nuvasive Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 108. Nuvasive Recent Developments and Future Plans
 Table 109. Cook Biotech Company Information, Head Office, and Major Competitors
 Table 110. Cook Biotech Major Business
 Table 111. Cook Biotech Regenerative Medicine Product and Solutions
 Table 112. Cook Biotech Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 113. Cook Biotech Recent Developments and Future Plans
 Table 114. Japan Tissue Engineering Company Information, Head Office, and Major Competitors
 Table 115. Japan Tissue Engineering Major Business
 Table 116. Japan Tissue Engineering Regenerative Medicine Product and Solutions
 Table 117. Japan Tissue Engineering Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 118. Japan Tissue Engineering Recent Developments and Future Plans
 Table 119. Global Regenerative Medicine Revenue (USD Million) by Players (2020-2025)
 Table 120. Global Regenerative Medicine Revenue Share by Players (2020-2025)
 Table 121. Breakdown of Regenerative Medicine by Company Type (Tier 1, Tier 2, and Tier 3)
 Table 122. Market Position of Players in Regenerative Medicine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
 Table 123. Head Office of Key Regenerative Medicine Players
 Table 124. Regenerative Medicine Market: Company Product Type Footprint
 Table 125. Regenerative Medicine Market: Company Product Application Footprint
 Table 126. Regenerative Medicine New Market Entrants and Barriers to Market Entry
 Table 127. Regenerative Medicine Mergers, Acquisition, Agreements, and Collaborations
 Table 128. Global Regenerative Medicine Consumption Value (USD Million) by Type (2020-2025)
 Table 129. Global Regenerative Medicine Consumption Value Share by Type (2020-2025)
 Table 130. Global Regenerative Medicine Consumption Value Forecast by Type (2026-2031)
 Table 131. Global Regenerative Medicine Consumption Value by Application (2020-2025)
 Table 132. Global Regenerative Medicine Consumption Value Forecast by Application (2026-2031)
 Table 133. North America Regenerative Medicine Consumption Value by Type (2020-2025) & (USD Million)
 Table 134. North America Regenerative Medicine Consumption Value by Type (2026-2031) & (USD Million)
 Table 135. North America Regenerative Medicine Consumption Value by Application (2020-2025) & (USD Million)
 Table 136. North America Regenerative Medicine Consumption Value by Application (2026-2031) & (USD Million)
 Table 137. North America Regenerative Medicine Consumption Value by Country (2020-2025) & (USD Million)
 Table 138. North America Regenerative Medicine Consumption Value by Country (2026-2031) & (USD Million)
 Table 139. Europe Regenerative Medicine Consumption Value by Type (2020-2025) & (USD Million)
 Table 140. Europe Regenerative Medicine Consumption Value by Type (2026-2031) & (USD Million)
 Table 141. Europe Regenerative Medicine Consumption Value by Application (2020-2025) & (USD Million)
 Table 142. Europe Regenerative Medicine Consumption Value by Application (2026-2031) & (USD Million)
 Table 143. Europe Regenerative Medicine Consumption Value by Country (2020-2025) & (USD Million)
 Table 144. Europe Regenerative Medicine Consumption Value by Country (2026-2031) & (USD Million)
 Table 145. Asia-Pacific Regenerative Medicine Consumption Value by Type (2020-2025) & (USD Million)
 Table 146. Asia-Pacific Regenerative Medicine Consumption Value by Type (2026-2031) & (USD Million)
 Table 147. Asia-Pacific Regenerative Medicine Consumption Value by Application (2020-2025) & (USD Million)
 Table 148. Asia-Pacific Regenerative Medicine Consumption Value by Application (2026-2031) & (USD Million)
 Table 149. Asia-Pacific Regenerative Medicine Consumption Value by Region (2020-2025) & (USD Million)
 Table 150. Asia-Pacific Regenerative Medicine Consumption Value by Region (2026-2031) & (USD Million)
 Table 151. South America Regenerative Medicine Consumption Value by Type (2020-2025) & (USD Million)
 Table 152. South America Regenerative Medicine Consumption Value by Type (2026-2031) & (USD Million)
 Table 153. South America Regenerative Medicine Consumption Value by Application (2020-2025) & (USD Million)
 Table 154. South America Regenerative Medicine Consumption Value by Application (2026-2031) & (USD Million)
 Table 155. South America Regenerative Medicine Consumption Value by Country (2020-2025) & (USD Million)
 Table 156. South America Regenerative Medicine Consumption Value by Country (2026-2031) & (USD Million)
 Table 157. Middle East & Africa Regenerative Medicine Consumption Value by Type (2020-2025) & (USD Million)
 Table 158. Middle East & Africa Regenerative Medicine Consumption Value by Type (2026-2031) & (USD Million)
 Table 159. Middle East & Africa Regenerative Medicine Consumption Value by Application (2020-2025) & (USD Million)
 Table 160. Middle East & Africa Regenerative Medicine Consumption Value by Application (2026-2031) & (USD Million)
 Table 161. Middle East & Africa Regenerative Medicine Consumption Value by Country (2020-2025) & (USD Million)
 Table 162. Middle East & Africa Regenerative Medicine Consumption Value by Country (2026-2031) & (USD Million)
 Table 163. Global Key Players of Regenerative Medicine Upstream (Raw Materials)
 Table 164. Global Regenerative Medicine Typical Customers


List of Figures
 Figure 1. Regenerative Medicine Picture
 Figure 2. Global Regenerative Medicine Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
 Figure 3. Global Regenerative Medicine Consumption Value Market Share by Type in 2024
 Figure 4. Cell Therapy
 Figure 5. Tissue Engineering
 Figure 6. Biomaterial
 Figure 7. Other
 Figure 8. Global Regenerative Medicine Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Figure 9. Regenerative Medicine Consumption Value Market Share by Application in 2024
 Figure 10. Dermatology Picture
 Figure 11. Cardiovascular Picture
 Figure 12. CNS Picture
 Figure 13. Orthopedic Picture
 Figure 14. Others Picture
 Figure 15. Global Regenerative Medicine Consumption Value, (USD Million): 2020 & 2024 & 2031
 Figure 16. Global Regenerative Medicine Consumption Value and Forecast (2020-2031) & (USD Million)
 Figure 17. Global Market Regenerative Medicine Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
 Figure 18. Global Regenerative Medicine Consumption Value Market Share by Region (2020-2031)
 Figure 19. Global Regenerative Medicine Consumption Value Market Share by Region in 2024
 Figure 20. North America Regenerative Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 21. Europe Regenerative Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 22. Asia-Pacific Regenerative Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 23. South America Regenerative Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 24. Middle East & Africa Regenerative Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 25. Company Three Recent Developments and Future Plans
 Figure 26. Global Regenerative Medicine Revenue Share by Players in 2024
 Figure 27. Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
 Figure 28. Market Share of Regenerative Medicine by Player Revenue in 2024
 Figure 29. Top 3 Regenerative Medicine Players Market Share in 2024
 Figure 30. Top 6 Regenerative Medicine Players Market Share in 2024
 Figure 31. Global Regenerative Medicine Consumption Value Share by Type (2020-2025)
 Figure 32. Global Regenerative Medicine Market Share Forecast by Type (2026-2031)
 Figure 33. Global Regenerative Medicine Consumption Value Share by Application (2020-2025)
 Figure 34. Global Regenerative Medicine Market Share Forecast by Application (2026-2031)
 Figure 35. North America Regenerative Medicine Consumption Value Market Share by Type (2020-2031)
 Figure 36. North America Regenerative Medicine Consumption Value Market Share by Application (2020-2031)
 Figure 37. North America Regenerative Medicine Consumption Value Market Share by Country (2020-2031)
 Figure 38. United States Regenerative Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 39. Canada Regenerative Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 40. Mexico Regenerative Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 41. Europe Regenerative Medicine Consumption Value Market Share by Type (2020-2031)
 Figure 42. Europe Regenerative Medicine Consumption Value Market Share by Application (2020-2031)
 Figure 43. Europe Regenerative Medicine Consumption Value Market Share by Country (2020-2031)
 Figure 44. Germany Regenerative Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 45. France Regenerative Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 46. United Kingdom Regenerative Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 47. Russia Regenerative Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 48. Italy Regenerative Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 49. Asia-Pacific Regenerative Medicine Consumption Value Market Share by Type (2020-2031)
 Figure 50. Asia-Pacific Regenerative Medicine Consumption Value Market Share by Application (2020-2031)
 Figure 51. Asia-Pacific Regenerative Medicine Consumption Value Market Share by Region (2020-2031)
 Figure 52. China Regenerative Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 53. Japan Regenerative Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 54. South Korea Regenerative Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 55. India Regenerative Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 56. Southeast Asia Regenerative Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 57. Australia Regenerative Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 58. South America Regenerative Medicine Consumption Value Market Share by Type (2020-2031)
 Figure 59. South America Regenerative Medicine Consumption Value Market Share by Application (2020-2031)
 Figure 60. South America Regenerative Medicine Consumption Value Market Share by Country (2020-2031)
 Figure 61. Brazil Regenerative Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 62. Argentina Regenerative Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 63. Middle East & Africa Regenerative Medicine Consumption Value Market Share by Type (2020-2031)
 Figure 64. Middle East & Africa Regenerative Medicine Consumption Value Market Share by Application (2020-2031)
 Figure 65. Middle East & Africa Regenerative Medicine Consumption Value Market Share by Country (2020-2031)
 Figure 66. Turkey Regenerative Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 67. Saudi Arabia Regenerative Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 68. UAE Regenerative Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 69. Regenerative Medicine Market Drivers
 Figure 70. Regenerative Medicine Market Restraints
 Figure 71. Regenerative Medicine Market Trends
 Figure 72. Porters Five Forces Analysis
 Figure 73. Regenerative Medicine Industrial Chain
 Figure 74. Methodology
 Figure 75. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

J & J (DePuy Synthes)
Medtronic
Zimmer Biomet
Stryker
Allergan(Acelity)
MiMedx Group
Organogenesis
Fujifilm Cellular Dynamics
Osiris Therapeutics
Vcanbio
CCBC
Cytori
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast
AMAG Pharmaceuticals (CBR)
ViaCord
CordLife
Integra LifeSciences
Nuvasive
Cook Biotech
Japan Tissue Engineering

Related Reports

Global Regenerative Medicine Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Regenerative Medicine Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Medical Care

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function". It is through the use of innovative medical means rebuilding diseased or damaged tissue or to support diseased or damaged tissue regeneration. The methods used include cell therapy, tissue engineering, chemically induced and therapeutic cloning, etc. Any combination of these technologies may be used to harness or stimulate the body’s innate healing ability in order to treat a wide range of ailments, including musculoskeletal-related conditions, cardio- and peripheral vascular diseases, neurological disorders, stroke, non-healing wounds and ocular diseases.

Global Regenerative Medicine Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Regenerative Medicine Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Regenerative Medicine market size was valued at USD 34340 million in 2023 and is forecast to a readjusted size of USD 111830 million by 2030 with a CAGR of 18.4% during review period.

Global Regenerative Medicine Supply, Demand and Key Producers, 2024-2030

Global Regenerative Medicine Supply, Demand and Key Producers, 2024-2030

date 19 Feb 2024

date Medical Care

The global Regenerative Medicine market size is expected to reach $ 111830 million by 2030, rising at a market growth of 18.4% CAGR during the forecast period (2024-2030).

Product Tags

Regenerative Medicine

Polysaccharide Natural Polymer Material for Regenerative Medicine

Regenerative Medicine Products

Translational Regenerative Medicine

Orthopedic Regenerative Medicine

Regenerative Medicine for Cartilage

Collagen and Gelatin for Regenerative Medicine

Cell Therapy Regenerative Medicine

Veterinary Regenerative Medicine

Natural Polymer Material for Regenerative Medicine

Protein Natural Polymer Material for Regenerative Medicine

Synthetic Polymer Material for Regenerative Medicine

Animal Regenerative Medicine and Stem Cell Therapy

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>